MGMS2
MGMS2 simulates membrane glycolipid mass spectra for polymicrobial samples, generating realistic matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectra for bacterial species in mixed microbial communities.
Key Features:
- In Silico Simulation: Generates in silico membrane glycolipid mass spectra representing MALDI-TOF signals from polymicrobial samples.
- Algorithmic Error Modeling: Incorporates algorithmic adjustments that account for errors in m/z values, variances in intensity values, missing signature ions, and noise peaks.
- Stand-Alone Simulator: Implements a stand-alone simulator specifically targeted at bacterial membrane glycolipid mass spectra.
- Validation and Performance: Demonstrated with six microbial species, producing in silico glycolipid mass spectra with a maximum correlation of approximately 87% to real polymicrobial spectra.
Scientific Applications:
- Machine Learning Training Data: Provides realistic simulated spectra to train and benchmark machine learning-based bacterial identification algorithms.
- Algorithm Development and Validation: Supports development and validation of algorithms to identify individual bacterial species within polymicrobial samples.
- Clinical and Microbiome Research: Enables evaluation of identification approaches relevant to clinical diagnostics, microbiome research, and infectious disease management using realistic polymicrobial spectra.
Methodology:
Simulates spectrum-to-spectrum variation and models m/z errors, intensity variance, missing signature ions, and noise peaks in generated MALDI-TOF membrane glycolipid mass spectra.
Topics
Details
- License:
- GPL-3.0
- Tool Type:
- library
- Programming Languages:
- R
- Added:
- 1/18/2021
- Last Updated:
- 2/22/2021
Operations
Publications
Ryu SY, Wendt GA, Ernst RK, Goodlett DR. MGMS2: Membrane glycolipid mass spectrum simulator for polymicrobial samples. Rapid Communications in Mass Spectrometry. 2020;34(16). doi:10.1002/rcm.8824. PMID:32384576. PMCID:PMC7466374.
DOI: 10.1002/RCM.8824
PMID: 32384576
PMCID: PMC7466374
Funding: - National Institute of General Medical Sciences: 1R01GM111066‐01, 1R15GM126562‐01, GM103440